Ocugen, inc. (HSGX)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14
Revenue

-

-

0

-

-

-

Revenue

-

-

-

0

0

0

Operating expenses
Research and development

8,085

10,321

15,566

21,577

23,243

26,037

General and administrative

6,077

5,819

9,384

8,530

8,266

6,565

Impairment of intangible asset

-

-

-

200

310

60

Total operating expenses

14,162

16,140

24,950

30,307

31,819

32,662

Loss from operations

-14,162

-16,140

-24,950

-30,307

-31,819

-32,662

Other income (expense)
Warrant expense

-

-

-

3,100

11

-

Change in fair value of warrant liability

-

-

1,482

-17,507

-

-

Change in fair value of derivative liabilities

-3,187

1,664

-

-

-

10,007

Loss on debt conversion

-341

0

-

-

-

-

Interest income

1

19

-

-

-

-

Interest income (expense), net

-

-

134

-60

-

-

Interest expense

1,767

3,750

-

-

133

151

Other income (expense)

-784

-12

-116

-248

-72

13

Total other income (expense)

-6,080

-2,079

-1,464

14,099

-205

9,869

Net loss

-20,200

-18,200

-26,414

-16,208

-32,024

-22,793

Loss attributable to common stockholders—basic

-

-

-22,499

-13,863

-32,024

-

Loss attributable to common stockholders—diluted

-

-

-22,499

-31,370

-32,024

-

Loss per common share—basic

-

-

-0.99

-0.97

-2.42

-

Loss per common share—diluted

-

-

-0.99

-2.18

-2.42

-

Weighted-average shares used to compute loss per common share—basic

-

-

22,669

14,256

13,231

-

Weighted-average shares used to compute loss per common share—diluted

-

-

22,669

14,389

13,231

-

Net loss per common share—basic and diluted

-

-

-

-

-

-10,510

Net loss per share of common stock - basic and diluted (in USD per share)

-1.46

-3.67

-

-

-

-6.85

Weighted average shares outstanding - basic and diluted (in shares)

13,893

4,960

-

-

-

1,534

Other comprehensive income (loss)
Foreign currency translation adjustment

-0

0

-

-

-

-

Comprehensive loss

-20,243

-18,219

-

-

-

-